Mabpharm Limited (2181) issued a letter dated 10 February 2026 to remind shareholders of its electronic dissemination arrangements for corporate communications. This follows the initial notification on 23 February 2024, which introduced the shift from printed copies to a digital format for key documents such as annual and interim reports, notices of meetings, and circulars.

The letter emphasizes that both English and Chinese versions of future corporate communications will be made available on the company’s official website and the HKEXnews website. Shareholders are encouraged to provide a valid email address—by scanning the personalized QR code on the enclosed reply form or by completing and returning the form—to ensure timely receipt of “Actionable Corporate Communications.” If no functional email address is provided, shareholders may need to check the websites proactively for new publications; they will only receive printed copies of documents requiring action.

The company also notes that shareholders who prefer printed copies of corporate communications may submit a request, which will remain valid for one year from the submission date. Details on how personal data is collected and used for these arrangements are included in the letter’s personal information collection statement.